Chinese | English
8th Asian Biologics and Biosimilars Congress
August 10-12, 2017 Beijing, China
Asian Biosimilars 2017 is a global annual event which brings together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. This conference would be your single best opportunity to reach the largest assemblage of participants from the Biosimilars community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community
the International Society for Pharmaceutical Engineering
August 23-26, 2017, Suntec Singapore
Organised by the Singapore affiliate of the International Society for Pharmaceutical Engineering (ISPE), this annual meeting is open to all pharma and bio manufacturing Professionals, with this year’s theme as “Innovating for Next Generation Pharma Manufacturing”. It is the must-attend industry event which highlights best practices, technology and services from manufacturing facility design to finished product. Conference Highlights: MORE! 20+ manufacturer and regulator insights, 6 Conference Tracks, 3 Workshops and 3 Tours, 5 Panel Discussions / Q&A round tables, ISPE PharmaNite & Networking Dinner, Regional Student Poster Competition Final, NEW! Breakfast Networking Session Exclusively for ISPE members, NEW! Blood Donation Drive with Red Cross
the 4th Annual Pharmacon Asia
September 19–22, 2017, Singapore
From Clinical Trials to Market Access, and against the bedrock of Regulatory Compliance, PharmaCon Asia will bring to you the full spectrum of the drug development and commercialisation value chain. The 4th Annual Congress is back with a new look, a compelling speaker line up and the opportunity to network across 3 separate events in one go. Conference Highlights: 60+ Commercial and Technical Papers; 12+ hours Of networking; 150+ Global, Regional and Local companies; Clinical Trial Trends, Spend areas, Regional Market updates and Operational Excellence; Market Access - Case Studies, Strategies and Practical Tips from Pharma; Regulatory Affairs Interpretation and implementation around the region, and practical compliance options
Bio Partnering APAC
September 20–21, 2017, Shanghai, China
Bio Partnering APAC 2017 is the most powerful way to make big deals in bio pharma industry in Asia Pacific Region. Against the background of increasing government policy support, exciting biotechnology breakthroughs and growing venture capital investment, themed on “Open Innovation, Strategic Cooperation”, Bio Partnering APAC 2017 will continuously provide you with the latest knowledge, tools and expertise to set your own global business strategy
BioPharm America™
September 26–27, 2017, Boston, MA
  BioPharm America™ is where biotech industry partnerships get started. This conference provides a proven and highly productive format for establishing new business relationships. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world's leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group's acclaimed European events BIO-Europe® and BIO-Europe Spring®
The 3rd World-China Super Generics Forum
October 19-20, 2017, Shanghai,China
Know about the latest Chinese and international laws and regulations to ensure products compliance. 2. Get the latest information about the development of generics to achieve the consistency. 3. Share bioequivalence test plan design to improve the pass rate of bioequivalence test. 4. Discuss about the innovation of chemical drugs development, drug delivery system and formulation. 5. Understand novel new drugs project approval and optimization of lead compounds. 6. Take part in the discussion of bundling review of formulation, pharmaceutical packaging materials and excipients. 7.Provide a platform for representatives from pharmaceutical companines, institutes and universities to communicate with each other
BIO-Europe® 2017-23rd Annual International Partnering Conference
November 6-9, 2017, Berlin, Germany
 The 23rd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry's most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum
BioPharma Development & Prodection Asia Pacific
November 6-9, 2017, Hilton, Singapore
The Asia Pacific biopharma development and production industry is growing rapidly, and it continues to evolve. Increase in adoption of innovative technology and investments in sophisticated R&D, coupled with higher manufacturing output are shaping to be the central tenets of the industry. Conference Highlights: 2 Co Located Conferences; Bioprocess and Technology - Manufacturing Trends, Capital Spending, Quality & Risk, Future Facilities; Biosimilars Markets - Regional Standards and Approvals, Risks, Opportunities and Competitive Advantage; 50+ Case Studies, Project Showcases, Commercial and Technical Papers; Regulatory Outlook - Interpretation, Guidelines for Biologics, Harmonisation, Disease Surveillance; Commercial Insights - Gaining Critical Mass in the Region and Getting the Strategy Right
4th BioCentury China Healthcare Summit
November 14-15, 2017, Shanghai, China
  The 2017 BioCentury China Healthcare Summit is an annual forum to identify the essential next steps to creating a modern healthcare ecosystem in China based on a foundation of scientific, business and policy innovations. This VIP event is organized by BioCentury and BayHelix in collaboration with McKinsey & Co. It is a closed-door meeting limited to senior-level biopharma and medtech executives, investors and academia. The Summit features two days of action-oriented discussion and networking among peers. Attendees will receive an exclusive conference report from McKinsey documenting market trends and identifying business imperatives for China healthcare innovators
BIFT 2017
December 5-6, 2017, Shanghai, China
Riding on the success of the meeting last year, Biologics Innovation and Frontier Technology (BIFT 2017) is the definitive conference in China for receiving first-hand information on the current international status of the Biopharmaceutical industry and China’s biopharmaceutical opportunities, bringing together decision makers across C level management, R&D and Manufacturing in the realms of biologic drugs, biosimilars, biotech and Immuno-oncology sectors
©Copyright 2013 - 2017 Lingmed Limited